No Data
No Data
Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Earnings and Shareholder Returns Have Been Trending Downwards for the Last Year, but the Stock Grows 4.3% This Past Week
The simplest way to benefit from a rising market is to buy an index fund. When you buy individual stocks, you can make higher profits, but you also face the risk of under-performance. That
Tianjin Chase Sun Pharmaceutical Co.,Ltd's (SZSE:300026) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
With its stock down 17% over the past three months, it is easy to disregard Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026). However, stock prices are usually driven by a company's financials over
Why You Might Be Interested In Tianjin Chase Sun Pharmaceutical Co.,Ltd (SZSE:300026) For Its Upcoming Dividend
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be intrigued to know that Tianjin Chase Sun Pharmaceutical Co.,Ltd (SZSE:300026) is ab
Red Sun Pharmaceutical (300026.SZ) plans to pay 0.3 yuan for every 10 shares in 2023, excluding interest on May 23
Hongri Pharmaceutical (300026.SZ) announced that the company plans to pay 0.30 for every 10 shares to all shareholders in 2023...
Tianjin Chase Sun PharmaceuticalLtd's (SZSE:300026) Sluggish Earnings Might Be Just The Beginning Of Its Problems
The subdued market reaction suggests that Tianjin Chase Sun Pharmaceutical Co.,Ltd's (SZSE:300026) recent earnings didn't contain any surprises. We think that investors are worried about some weaknes
Not Many Are Piling Into Tianjin Chase Sun Pharmaceutical Co.,Ltd (SZSE:300026) Just Yet
When close to half the companies in China have price-to-earnings ratios (or "P/E's") above 31x, you may consider Tianjin Chase Sun Pharmaceutical Co.,Ltd (SZSE:300026) as an attractive investment with